mads u werner: Clinical Trials

4 trials sponsored by mads u werner, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Completed 1

Follow mads u werner: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of High-dose Naloxone Following Third Molar Extraction
Naloxone, Normal Saline - Healthy Subjects, Hyperalgesia
Phase 2Completedmads u werner232017-10-122024-02-22
Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury
Naloxone, Normal saline - Healthy Subjects
Phase 2Completedmads u werner802016-02-012024-02-23
Analgesic and Antihyperalgesic Effects of Morphine and Buprenorphine
morphine LO, Morphine Hi, Buprenorphine LO - Pain
Not applicableCompletedmads u werner342011-02-012016-11-28
Does Re-surgery Improve Somatosensory Outcomes in Persistent Pain After Groin Hernia Repair
Re-surgery - Patients With Persistent Severe Pain After Groin Hernia Repair
Completedmads u werner602009-04-242022-11-28

Conditions studied

Hyperalgesia (3)  ·  Pain (2)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Burns (1)  ·  Pain, Postoperative (1)  ·  Pulpitis (1)

Interventions

Saline Solution (3)  ·  Naloxone (2)  ·  Buprenorphine (1)  ·  Sodium Chloride (1)

Countries

Denmark (4)

Top investigators

Bradley K Taylor, M.Sc., Ph.D. (2)  ·  Lona L Christrup, MSc, PhD (1)

Results publications

PMID 16275600, PMID 21300053, PMID 23741350, PMID 24052307, PMID 26305798, PMID 11576045, PMID 15560360, PMID 16202520, PMID 23359655, PMID 23671631, PMID 24012952, PMID 25227929, PMID 8109774